Applied StemCell
Milpitas, CA
No confirmed program data — ClinicalTrials.gov verification pending
· Last scored 2026-09-07
59.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (4)
○ EMA GMP
○ MHRA GMP
Quick Facts: Applied StemCell
- Signal Score
- 59.0/100 (as of 2026-09-07)
- Quality Compliance
- Assessment pending
- Headquarters
- Milpitas, CA
- Modalities
- Cell Therapy, Gene Editing
- Active Programs
- Data pending
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Applied StemCell
Pure-play CDMO.
Signal Score & Pillar Breakdown
Scores are being republished.
Scores are being republished under methodology v3.3. The score shown is the last complete v3.2 result, which is also what directory listings and search results show. A pillar breakdown is not shown because the current one is computed under v3.3 and would not explain a v3.2 score. Regulatory evidence below is current.
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCell Therapy, Gene Editing
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Profile-based financial assessment
SEC FilingsPrivate company
Capacity
58.0
Profile-based capacity assessment
Recent Press4 articles
Recent News 4 articles
Applied StemCell and Cellipont Bioservices Partner to Offer - GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development - The Manila Times
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development The Manila Times
Applied StemCell and Cellipont Bioservices Partner to Offer - GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer GlobeNewswire
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development - BioSpace
Applied StemCell and Cellipont Bioservices Partner to Offer a Seamless Path for iPSC-Derived Cell Therapy Development BioSpace
Frequently Asked Questions About Applied StemCell
What is Applied StemCell's CDMO Signal Score?
Applied StemCell has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Applied StemCell for a manufacturing program?
Use the free AI matchmaker to compare Applied StemCell against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 90.9
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Bayer (Cell Therapy Mfg)
Berkeley, CA
Signal Score: 80.4
Cell Therapy, Gene Editing
Cedars-Sinai Biomanufacturing
Los Angeles, CA
Signal Score: 79.8
Cell Therapy, Gene Editing
Green Phoenix Labs
San Diego, CA
Signal Score: 78.1
Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing